Third agents for type 2 diabetes are similar in efficacy

Advisers with the FDA endorse a monoclonal antibody treatment for RSV in children, AstraZeneca and Quell sign a $2 billion agreement, and HSS hopes to strengthen the pediatric workforce.

Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.

Nivolumab plus relatlimab showed a clear benefit in progression-free survival, overall survival and objective response rate.

Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.

A survey found that only 24.6% of respondents have conducted a skin self-examination in the past 2 months.

The newly approved at-home test was effective in trials, correctly identifying 98.7% of negative and 92.9% of positive samples for individuals with symptoms of upper respiratory infection.